| CAS ID: | 1450824-22-2 |
| Molecular Formula: | C28H30F2N6O8S |
| Molecular Weight: | 648.6 g/mol |
| Monoisotopic Mass: | 648.181 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C28H30F2N6O8S/c29-15-5-1-3-13(7-15)17-9-35(33-31-17)21-23(39)19(11-37)43-27(25(21)41)45-28-26(42)22(24(40)20(12-38)44-28)36-10-18(32-34-36)14-4-2-6-16(30)8-14/h1-10,19-28,37-42H,11-12H2/t19-,20-,21+,22+,23+,24+,25-,26-,27+,28+/m1/s1 | See All |
| InChI Key: | YGIDGBAHDZEYMT-MQFIMZJJSA-N | |
| Smiles: | C1=CC(=CC(=C1)F)C2=CN(N=N2)C3C(C(OC(C3O)SC4C(C(C(C(O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O | See All |
| Molfile: |
Trial Record 1
| ClinicalTrial ID | NCT02257177 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 1,Phase 2 | Status | Completed |
| First Received | October 6, 2014 | Last Verified | January 5, 2017 |
| Sponsor | Galecto Biotech AB | ||
| PubChem: | 73774610 |
| ChEMBL: |